CAL
AMRX icon

Capital Advisors Ltd’s Amneal Pharmaceuticals AMRX Stock Holding History

Capital Advisors Ltd’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
8
– – ﹤0.01% 1347
2026
Q1 		$0 Hold
8
– – ﹤0.01% 1345
2025
Q4 		$0 Hold
8
– – ﹤0.01% 1330
2025
Q3 		$0 Hold
8
– – ﹤0.01% 1337
2025
Q2 		$0 Hold
8
– – ﹤0.01% 1321
2025
Q1 		$0 Hold
8
– – ﹤0.01% 1320
2024
Q4 		$0 Hold
8
– – ﹤0.01% 1353
2024
Q3 		$0 Hold
8
– – ﹤0.01% 1352
2024
Q2 		$0 Hold
8
– – ﹤0.01% 1361
2024
Q1 		$0 Hold
8
– – ﹤0.01% 1336
2023
Q4 		$0 Hold
8
– – ﹤0.01% 1277
2023
Q3 		$0 Hold
8
– – ﹤0.01% 1270
2023
Q2 		$0 Buy
+8
New +$17 ﹤0.01% 1274

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Capital Advisors Ltd's AMRX Position: Q2 2026 in Review

Capital Advisors Ltd held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Capital Advisors Ltd first reported a position in AMRX in Q2 2023 and has held it in 13 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Capital Advisors Ltd held 8 shares of Amneal Pharmaceuticals worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1347 holding.
  • Capital Advisors Ltd first reported a position in Amneal Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.